N-phenylmaleimide

structure in Merck Index, 9th ed, #7104

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Neuroblastoma 02/14/2012 - "In these lines, we confirmed the effects of 2-arachidonoylglycerol (2-AG), the main endocannabinoid, on neuroblastoma cells proliferation in vitro, and proved that some N-phenylmaleimide compounds that were previously shown as MAGL inhibitors can also inhibit type 2 topoisomerase. "
2.	Neoplasms (Cancer) 11/23/2020 - "To determine the mechanism through which OGC promotes tumor growth, the effects of the OGC inhibitor N-phenylmaleimide (NPM) on mitochondrial activity, oxygen consumption, and ATP production were evaluated in melanoma cell lines. "
3.	Melanoma (Melanoma, Malignant) 11/23/2020 - "To determine the mechanism through which OGC promotes tumor growth, the effects of the OGC inhibitor N-phenylmaleimide (NPM) on mitochondrial activity, oxygen consumption, and ATP production were evaluated in melanoma cell lines. "
4.	Infections 11/23/2018 - "Results indicated that AIF translocated from the mitochondria to nucleus during TGEV infection, and the AIF inhibitor, N-phenylmaleimide (NP), significantly attenuated the apoptosis. "
5.	Dehydration (Water Stress) 04/07/2003 - "These compounds undergo in situ cyclodimerization of the [4 + 2]-type upon dehydration of the precursor tertiary alcohols and form endo-adducts in the Diels-Alder reaction with N-phenylmaleimide. "

1.	Endocannabinoids
2.	Alcohols
3.	Adenosine Triphosphate (ATP)
4.	glyceryl 2-arachidonate (2-arachidonoylglycerol)